FER1L4 and prostate cancer: Depletion of FBXW7 abolished the cell proliferation inhibition caused by FER1L4 upregulation in prostate cancer cells, indicating that FER1L4 exerts antitumor activity through the miR-92a3p/FBXW7 axis (89).